2.11 (14H, m, quinolizidine ring protons), 2.66–2.82 (2H, m, quinolizidine ring H-1 and H-9a), 3.58–3.70, 3.82–4.00 (2H, 2m,
quinolizidine ring CH -1), 7.75–7.94 (4H, m, phthalimide protons).
2
[(1R,9aR)-Octahydro-2H-quinolizin-1-ylmethyl]amine (2). A solution of 1c (12.1 g, 40.5 mmol) in EtOH (50 mL)
was treated with hydrazine hydrate (2.2 mL, 45.3 mmol), refluxed for 2 h, cooled, and filtered. The filtrate was cooled, stirred,
and purged with a stream of anhydrous HCl. The resulting precipitate of lupinylamine dihydrochloride was filtered off and
washed with acetone. Yield 9.09 g (92.8%), C H N ·2HCl, mp >300°C (EtOH). PMR spectrum (400 MHz, CDCl , ꢁ,
10 20
2
3
+
+
ppm): 1.12–2.13 (9H, m), 2.62–3.46 (9H, m), 8.31 (2H, br.s, NH ), 10.95 (1H, br.s, NH ).
3
The precipitate was dissolved in H O (100 mL), treated with KOH solution (4 g KOH in 10 mL H O), and extracted
2
2
with Et O (3 ꢂ 50 mL). The extract was dried over Na SO . The Et O was distilled. Yield 5.1 g (80%). The product was used
2
2
4
2
without further purification.
General Method for Synthesizing 4a–d and 6a–c. A hot solution of the appropriate 7-hydroxyisoflavone (3a–d,
2 mmol) or 7-hydroxy-3-arylcoumarin (5a–c, 2 mmol) in propan-2-ol (20 mL) was treated with lupinylamine (2.2 mmol),
formalin (1.2 mL, 37%), and DMAP (5 mg). The mixture was refluxed for 3–5 h (end of reaction determined by TLC), cooled,
and evaporated in vacuo. The solid was crystallized from a mixture of propan-2-ol and hexane.
3-(4-Methoxyphenyl)-9-[(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl]-9,10-dihydro-4H,8H-chromeno[8,
7-e][1,3]oxazin-4-one (4a). C H N O , yield 72%, mp 170–171°C (propan-2-ol:hexane). PMR spectrum (400 MHz,
28 32
2 4
CDCl , ꢁ, ppm, J/Hz): 1.08–2.15 (14H, m, quinolizidine ring), 2.71–3.07 (4H, m, quinolizidine ring H-1 and H-9a, N–CH -9),
3
2
2
3
3.80 (3H, s, 4ꢀ-OMe), 4.11 (2H, s, CH -10), 4.89, 4.93 (2H, 2d, J = 10.0, CH -8), 6.84 (1H, d, J = 9.0, H-6), 6.93 (2H, d,
J = 8.4, H-3ꢀ, H-5ꢀ), 7.45 (2H, d, J = 8.4, H-2ꢀ, H-6ꢀ), 7.87 (1H, s, H-2), 8.05 (1H, d, J = 9.0, H-5).
2
2
3
3
3
3-(2-Methoxyphenyl)-9-[(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl]-9,10-dihydro-4H,8H-chromeno[8,
7-e][1,3]oxazin-4-one (4b). C H N O , yield 68%, mp 206–208°C (propan-2-ol:hexane). PMR spectrum (400 MHz,
28 32
2 4
CDCl , ꢁ, ppm, J/Hz): 1.11–2.12 (14H, m, quinolizidine ring), 2.74–3.04 (4H, m, quinolizidine ring H-1 and H-9a, N–CH -9),
3
2
2
3
3.80 (3H, s, 2ꢀ-OMe), 4.12 (2H, s, CH -10), 4.88, 4.93 (2H, 2d, J = 10.0, CH -8), 6.84 (1H, d, J = 8.8, H-6), 6.93–7.02 (2H,
m, H-3ꢀ, H-5ꢀ), 7.24–7.36 (2H, m, H-4ꢀ, H-6ꢀ), 7.85 (1H, s, H-2), 8.04 (1H, d, J = 8.8, H-5).
2
2
3
2-Methyl-9-[(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl]-3-phenyl-9,10-dihydro-4H,8H-chromeno[8,
7-e][1,3]oxazin-4-one (4c). C H N O , yield 53%, mp 130–132°C (propan-2-ol:hexane). PMR spectrum (400 MHz,
28 32
2 3
CDCl , ꢁ, ppm, J/Hz): 1.14–2.16 (14H, m, quinolizidine ring), 2.29 (3H, s, CH -2), 2.75–3.04 (4H, m, quinolizidine ring
3
3
2
3
H-1 and H-9a, N–CH -9), 4.11 (2H, s, CH -10), 4.88, 4.92 (2H, 2d, J = 10.0, CH -8), 6.80 (1H, d, J = 8.8, H-6), 7.20–7.46
(5H, m, Ph-3), 7.97 (1H, d, J = 8.8, H-5).
2
2
2
3
2-Methyl-3-(2-methoxyphenyl)-9-[(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl]-9,10-dihydro-4H,8H-
chromeno[8,7-e][1,3]oxazin-4-one (4d). C H N O , yield 48%, mp 145–146°C (propan-2-ol:hexane). PMR spectrum
29 34
2 4
(400 MHz, CDCl , ꢁ, ppm, J/Hz): 1.14–2.16 (14H, m, quinolizidine ring), 2.21 (3H, s, CH -2), 2.79–3.03 (4H, m, quinolizidine
3
3
3
ring H-1 and H-9a, N–CH -9), 3.78 (3H, s, 2ꢀ-OMe), 4.15 (2H, s, CH -10), 4.93 (2H, s, CH -8), 6.81 (1H, d, J = 8.9, H-6),
2
2
2
3
6.95–7.05 (2H, m, H-3ꢀ, H-5ꢀ), 7.14–7.19 (1H, m, H-6ꢀ), 7.32–7.39 (1H, m, H-4ꢀ), 7.99 (1H, d, J = 8.9, H-5).
3-(3-Methoxyphenyl)-9-[(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl]-9,10-dihydro-2H,8H-chromeno[8,
7-e][1,3]oxazin-4-one (6a). C H N O , yield 55%, mp 181–182°C (propan-2-ol:hexane). PMR spectrum (400 MHz,
28 32
2 4
CDCl , ꢁ, ppm, J/Hz): 1.14–2.10 (14H, m, quinolizidine ring), 2.75–3.02 (4H, m, quinolizidine ring H-1 and H-9a, N–CH -9),
3
2
2
2
3
3.86 (3H, s, 3ꢀ-OMe), 4.13, 4.18 (2H, 2d, J = 17.1, CH -10), 4.90, 4.96 (2H, 2d, J = 9.5, CH -8), 6.76 (1H, d, J = 8.8, H-6),
6.91–6.96 (1H, m, H-4ꢀ), 7.22–7.26 (2H, m, H-2ꢀ, H-6ꢀ), 7.29 (1H, d, J = 8.8, H-5), 7.32–7.38 (1H, m, H-5ꢀ), 7.74 (1H, s,
H-4).
2
2
3
3-(2,4-Dimethoxyphenyl)-9-[(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl]-9,10-dihydro-2H,8H-
chromeno[8,7-e][1,3]oxazin-4-one (6b). C H N O , yield 68%, mp 118–120°C (propan-2-ol:hexane). PMR spectrum
29 34
2 5
(400 MHz, CDCl , ꢁ, ppm, J/Hz): 1.07–2.13 (14H, m, quinolizidine ring), 2.75–3.03 (4H, m, quinolizidine ring H-1 and H-9a,
3
2
2
N–CH -9), 3.80, 3.84 (6H, 2s, 2ꢀ-OMe, 4ꢀ-OMe), 4.11, 4.17 (2H, 2d, J = 17.1, CH -10), 4.88, 4.95 (2H, 2d, J = 9.5, CH -8),
6.52–6.58 (2H, m, H-3ꢀ, H-5ꢀ), 6.72 (1H, d, J = 8.1, H-6), 7.23 (1H, d, J = 8.1, H-5), 7.26–7.31 (1H, m, H-3ꢀ), 7.62 (1H, s,
H-4).
2
2
2
3
3
3-(2,5-Dimethoxyphenyl)-9-[(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl]-9,10-dihydro-2H,8H-
chromeno[8,7-e][1,3]oxazin-4-one (6c). C H N O , yield 57%, mp 135–136°C (propan-2-ol:hexane). PMR spectrum
29 34
2 5
(400 MHz, CDCl , ꢁ, ppm, J/Hz): 1.12–2.15 (14H, m, quinolizidine ring), 2.77–3.01 (4H, m, quinolizidine ring H-1 and H-9a,
3
2
2
N–CH -9), 3.79, 3.80 (6H, 2s, 2ꢀ-OMe, 5ꢀ-OMe), 4.12, 4.19 (2H, 2d, J = 17.6, CH -10), 4.90, 4.97 (2H, 2d, J = 10.0,
CH -8), 6.75 (1H, d, J = 9.0, H-6), 6.60–6.96 (3H, m, H-3ꢀ, H-4ꢀ, H-6ꢀ), 7.23 (1H, d, J = 9.0, H-5), 7.67 (1H, s, H-4).
2
2
3
3
2
236